Introduction
============

Malaria is a global public health threat infecting an estimated 212 million and causing 429, 000 deaths in 2015. However, the current prevention and control measures have led to a 29% reduction in malaria mortality rates globally. Sub-Saharan Africa still carries a huge share of malaria burden. Thus, the continent has been home to 90% of malaria morbidity and 92% of mortality rates ([@R1]). In response to the emergence and spread of Plasmodium falciparum resistance to chloroquine (CQ) and sulfadoxine- pyrimethamine (SP), the World Health Organization (WHO) has recommended the use of artemisinin-based combination therapy (ACT). ACTs have been used in reducing malaria burden and play an important role in maintaining the current success of control programs ([@R2]). Nowadays, the increase in global travel and population movement augments resistant parasite spread to any part of the world ([@R3]--[@R5]) leading to treatment failures and decreased efficacies. Emergence and spread of P. falciparum resistance to ACTs in South-eastern Asia threaten global malaria efforts. The declining efficacy of the classical antimalarial medicines, resistance of vectors to insecticides and failure of developing effective vaccines have led to an urgent need for searching new and efficient antiplasmodial candidates from natural products ([@R6],[@R7]).

Studies uncovered that modern pharmacopeia still contains at least 25% drugs derived from plants and many others which are synthetic analogs built on prototype compounds isolated from plants ([@R8],[@R9]). About 90% of the Ethiopian population rely on traditional medicines including herbal products for their primary health care needs ([@R10]). Moreover, medicinal plants have played a profound role for the treatment of human malaria due to the presence of antiplasmodial compounds in several plant species ([@R11]). Quinine, for instance, was extracted from Cinchona bark, while CQ and primaquine were synthesized as new antiplasmodial agents, artemisinin, a potent partner drug in ACTs, was discovered from the Chinese medicinal plant by the Noble prize winner Chinese Professor, Tu Youyou ([@R12]).

Artemisia annua, the only available effective antimalarial drug against resistant strains of Plasmodium parasites ([@R13]). It attracted the attention of many researchers and stakeholders to look for new antiplasmodial remedies from natural products.

In Ethiopia, there are a number of medicinal plants traditionally used for the treatment of malaria and/or fever. Among which Zingiber officinale Roscoe and the indigenous plant, *Echinops kebericho* Mesfin are the two most common ones ([@R14], [@R15]).

*Echinops* is one of the genera classified under the family *Asteraceae. E. kebericho* Mesfin (*Qabarichoo* in Afaan Oromoo) is endemic to Ethiopia confined only to the highlands ([@R14]). *Kebericho* is so far known from a few localities in Ethiopia (Shawa and Gojam Provinces) at altitudes of 2300--2600 m. It is an erect perennial herb or shrub up to 1.2 m high, commonly from a massive root stock with leafy stems ([@R16]). It has long been traditionally used specifically by the local practitioners (healers) against a wide range of ailments. These include malaria, migraine, mental illness, heart pain, lung Tuberculosis, leprosy, kidney disease, bilharzia, syphilis and amoebic dysentery ([@R14]).

*Z. officinale* Roscoe is commonly called Ginger, African ginger or Black ginger. It belongs to *Zingiberaceae* family. Ginger is a 2--4 foot tall perennial with grass like leaves up to a foot in length. *Z. officinale* Roscoe is mostly distributed in Asia, Africa, India, Jamaica, Mexico, and Hawaii ([@R17]) and it has been widely used in West African countries as an antimalarial agent ([@R18]--[@R20]). In general, the two medicinal plants have wider medicinal applications; therefore, this study was designed to investigate the traditional claims of antimalarial efficacy and safety of their use within the community using *in vivo* antiplasmodial activity and acute toxicity profiles.

Methods
=======

Extraction of the plant material was conducted at Jimma University Laboratory of Drug Quality (JuLaDQ). The acute toxicity and antiplasmodial activity studies were conducted at Jimma University College of Agriculture and Veterinary Medicine, Experimental Research Laboratory from January to May n 2012.

**Collection and preparation of plant material:** Fresh rhizomes of *Echinops kebericho* Mesfin and roots of *Z. officinale* Roscoe were collected from Gindabarat, Gonfi Kedida which is located at an attitude of 9 33′ 00″ and longitude 37 53′ 00″ ([@R21]), West Oromia 200 km from Addis Ababa, Ethiopia. The plant materials were wrapped with plastic sheets during transportation. Collection of the plants was guided by the traditional healers, and species identification of the plants was made by a botanist at Jimma University herbarium. Plant specimens were deposited with voucher numbers 2348 and 2347 for *E. kebericho* Mesfin and *Z. officinale* Roscoe, respectively, at Jimma University Herbarium.

**Extraction of plant materials**: The plant materials were air dried at room temperature under shade and grounded to a powder using mortar and pestle. A total of 100 g of each plant material was extracted using Soxhlet apparatus with 400 ml of 70% methanol. The mixtures were filtered using Whatman filter paper No.2 (Whatman®, England). Methanol was evaporated from the extracts by a rotary evaporator (Buchi Rota vapor, Switzerland) under low pressure, and the final filtrate was stored in a tightly closed bottle container at 4°C until used ([@R22]). Each fresh experimental solute was prepared by 3% Tween 80 (Sigma - Aldrich).

**The parasites**: Chloroquine sensitive P. berghei strain ANKA was obtained from Ethiopian Public Health Institute (EPHI) and maintained at the Animal House of Jimma University College of Agriculture and Veterinary Medicine (JUCAVM). The viability of parasites was maintained by serial passage at a standard inoculum of 1×10^7^ of parasitized erythrocytes from donor mice to healthy ones in the experimental laboratory as described elsewhere ([@R23], [@R24]).

**The experimental animal**: Male Swiss albino NMRI mice 4--5 weeks of age and 25--36 g were procured from the breeding colony of School of JUCAVM, and donor mice were obtained from EPHI. They were then maintained on commercial pellet and water ad libitum and kept in 12 h dark and 12 h light in clean and fly-proof house stable one week prior to the commencement of experiment for acclimatization purpose. The health of the mice was followed by a veterinarian. The care of experimental animals was followed according to the standard set by the international guideline for animal care and use. The animals were then randomly assigned to different treatment groups of five, each in a cage.

**Oral acute toxicity test**: Twenty albino mice aged 4--5 weeks and weighing 25--36 g were randomly grouped into four groups of 5 mice; three treatment groups and one control group. The mice in the control group received 3% tween 80 (vehicle), whereas the crude extracts of *E. Kebericho* Mesfin were orally administered in a vehicle using oral gavages at doses 5000, 2500 and 1250 mg/kg body weight.

Then, the mice were observed continuously for 4 h after administering the crude extract and followed for 24 h for any manifestations of toxicity. The median lethal dose (LD50) of the crude extracts was determined according to the method described earlier ([@R25]). Oral acute toxicity parameters such as body weight (measured on day 1, day 7 and day 14), hematological assay ([@R26]) and histopathological indices were determined on day 14 ([@R27]). It was reported that the toxicity of ginger had already been conducted and considered negligible with oral LD50 values in various animals exceeding 5 g/Kg([@R28]). Besides this fact, the plant has been recognized by U.S. Food and Drug Administration generally recognized as safe food supplement ([@R29]). Because of this report, we did not conduct the toxicity profiles of *Z. officinale Roscoe.*

**In vivo antiplasmodial activity studies**: Antiplasmodial activity of each of the test extracts was performed in a 4-day suppressive standard test as described earlier ([@R30]). Forty male Swiss Albino mice 4--5 weeks and weight 25--36 g were used to evaluate the antiplasmodial activity of both plant extracts. Donor mice infected with rodent malaria parasite, *P. berghei* (with a raised parasitemia of 20--30%) were sacrificed, and blood was collected via cardiac puncture with a sterile and disposable needle and syringe. The blood was diluted with normal saline in such a way that 0.2 ml of blood contained approximately 1--10^7^ infected red blood cells ([@R31]). Each mouse was inoculated intraperitoneally with 0.2 ml of infected blood on the first day (D 0). The mice were then divided randomly into eight groups of five mice in each group. Three groups of mice were assigned to different treatment groups, and the other two groups were used as common controls (positive and negative). Three hours post infection, the treatment groups were orally administered with 1000, 500 and 250 mg/kg/day doses of each plant extract. Chloroquine tablet, (Batch Number 0123C3RJA, Addis Pharmaceuticals Factory PLC Adgrat, Ethiopia) at the dose of 25 mg/kg/day and vehicle (3% Tween 80) were administered orally to the positive and negative control groups, respectively, for four consecutive days (D 0 to D 3).

On the fifth day (D 4), drops of blood were taken from the tail of each mouse and thick, and thin smears were made on the microscopic slide. The smears were then fixed with methanol and stained with 10% Giemsa. Four fields were examined on each slide. The number of infected and uninfected red blood cells were counted and the mean was taken according to previous works ([@R31]): $$\text{Parasitaemia~=}\frac{\text{Total~iRBCs}}{\text{Total~RBCs~counted}}x100\%$$

The percentage parasitemia and chemosuppressions were calculated according to the standardized test methods ([@R24],[@R32]). Therefore, the difference between the mean parasitemia value of the control group (taken as 100%), and those of the experimental groups was calculated and expressed as percent reduction (activity) using either of the following Equations 1 and 2 ([@R31]): $${Activity} = 100\  - \left\{ \frac{{mean}\ {parasitaemia}\ {in}\ {treated}}{{mean}\ {parasitaemia}\ {in}\ {control}} \right.$$

Or $$\text{\%chemosupression} = \frac{\text{Parasitaemia~in~negative~control} - \text{Parataemia~in~study~group}}{{Parasitaemia}\ {in}\ {Negative}\ {control}}$$

Thus, a plant extract is considered to have antiplasmodial activity if it shows a reduction in parasitemia ≥ 30% ([@R33]).

**Determination of packed cell volume and body weight of the mice**: The PCV was measured to predict the effectiveness of the test extracts ([@R34]) on D 4. Blood from the tail of each animal was drawn in duplicate, and measurements were done as follows: $${Packed}\ {Cell}\ {Volume} = \frac{{Volume}\ {of}\ {erythrocytes}\ {in}\ a\ {gived}\ {volume}\ {of}\ {blood}}{{Total}\ {blood}\ {Volume}}$$

On D 0 and D 4, the body weight of each mouse was determined to observe whether the test extracts prevented the weight loss. The body weights of mice are commonly reduced with increasing parasitemia in infected mice ([@R26]).

**Monitoring mean survival time**: Mortality was monitored daily, and the number of days from the time of inoculation of the parasite up to death was recorded for each mouse in the treatment and control groups throughout the follow-up period. The mean survival time (MST) for each group was calculated using Equation 4 ([@R35]): $${MST} = \frac{{Sum}\ {of}\ {survival}\ {times}\ {of}\ {all}\ {mice}\ {in}\ a\ {group}\ ({days}}{{Total}\ {numbers}\ {of}\ {mice}\ {in}\ {that}\ {group}}$$

**Data analysis**: Results were presented as a mean ± standard error of the mean (M ± SEM). SPSS Version 20 was used for the analysis of data of parasitemia, body weight, PCV, and survival times. Statistical significance was determined by one-way ANOVA. Independent t-test was used to compare results. All data were analyzed at a 95% confidence interval (α= 0.05) ([@R26]).

Results
=======

**Oral acute toxicity assessment of Echinops Kebericho Mesfin**: Oral acute toxicity studies revealed that the graded doses of 70% methanol extract of *E. Kebericho* Mesfin (maximum 5,000 mg/kg) did not show any signs of toxicity in mice. The experimental maximum dose did not show any lethal effects; revealing that the LD50 could be beyond the dose used. In this *in vivo* acute toxicity study, there was no gross physical and behavioral changes such as rigidity, sleep, diarrhea, depression, abnormal secretion and hair erection. Moreover, there were no significant differences between the control groups and the experimental arms with regard to body weight, hematological and histopathological parameters ([Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}) at the aforementioned doses.

###### 

Effects of 70% methanol rhizome extract of *Echinops kebericho* Mesfin on body weight of mice in oral acute toxicity studies

  ----------------------------------------------------------------------------------------------
  Treatment group\   Body weight(g) on three different days                              
  (does in mg/kg)                                                                        
  ------------------ ---------------------------------------- ------------- ------------ -------
  5000 mg/kg         33.00±1.650                              32.67±1.43    35.0±1.26    0.490

  2500 mg/kg         32.00±1.00                               35.33±1.28    38.33±0.61   0.002

  1250 mg/kg         28.50±0.99                               32.83±0.98    37.0±0.816   0.000

  Control            26.17±2.50                               33.00±2.113   36.67±1.23   0.007
  ----------------------------------------------------------------------------------------------

Key: Values are expressed as MEAN±SEM, n=6, day 0= initial day pretreatment weight: D 7=weight on day 7: D 14= weight on day 14

###### 

The effect of 70% methanol extracts of the rhizome of Echinops kebericho Mesfin on Haematological parameters in oral acute toxicity studies

  -------------------------------------------------------------------------------------
  Treatment group\   Haematological parameters                             
  (does in mg/kg)                                                          
  ------------------ --------------------------- ------------ ------------ ------------
  5000               3.53±0.79                   7.93±1.64    10.78±2.22   40.18±8.31

  2500               3.17±0.52                   9.78±0.53    13.32±0.63   50.21±2.72

  1250               4.14±0.59                   10.25±0.62   13.97±0.71   47.82±1.03

  Control            3.17±0.15                   8.78±0.35    12.88±0.45   49.70±0.96
  -------------------------------------------------------------------------------------

Key: Values are expressed as Mean±SEM: n=6: TWBC=Total White Blood Cells: RBC= Red Blood Cells: Hgb=Haemoglobin: HCT=Haematocrit

**In vivo antiplasmodial Studies**: In a four day suppressive tests, the in vivo antiplasmodial studies of the methanol extracts of both plants showed significant chemo-suppressions in a dose-dependent manner as compared to the negative control ([Table 4](#T4){ref-type="table"}). Accordingly, the highest parasitemia suppressive effects of the rhizome extract of *E. Kebericho* Mesfin were 49.53 ± 1.90, 34.66 ± 0.76, and 22.13 ± 0.87 for 1000, 500, and 250 mg/kg/body weight; respectively ([Table 4](#T4){ref-type="table"}). The antiplasmodial activities of *Z. officinale* Roscoe were also 32.83 ± 1.03, 23.49 ± 1.47, 19.87 ± 0.84 for 1000, 500, and 250 mg/kg/body weight; respectively. It can easily be inferred that the first and the second highest doses of both plant extracts showed profound chemo-suppression (P \<0.001) *in P. berghei* infected animals. On the other hand, 1000 mg/kg of *E. Kebericho* Mesfin rhizome extract was found to be promising antiplasmodial activity than other graded doses.

###### 

Effects of 70% methanol rhizome extracts of *Echinops kebericho* Mesfin and *Z. officinale Roscoe* on % parasitemia, chemo-suppression and survival times of *P. berghei* infected mice

  -------------------------------------------------------------------------------------
  Extracts           Doses (mg/kg)   \% Parasitemia   \% Inhibition\   Survival time\
                                                      (activity)       (days)
  ------------------ --------------- ---------------- ---------------- ----------------
  *E.. kebericho*    1000            50.18±1.90       49.53±1.90       10.31±0.67

                     500             65.28±0.764      34.66±0.76       9.91±0.63

                     250             77.780±0.87      22.13±0.87       6.78±0.20

  *Z. officinale*    1000            67.06±1.03       32.83±1.03       7.33±0.51

                     500             76.31±1.49       23.49±1.47       6.38±0.24

                     250             80.03±0.84       19.87±0.84       6.28±0.20

  25 mg/kg CQ                        5.14±0.37        94.79±0.37417    13.00±0.00

  Negative control                   100.00±0.00      0.00             6.18±0.20
  -------------------------------------------------------------------------------------

Key: Values are expressed as Mean±SEM, n=5: TWN80=Tween80

Extracts of both plants failed to protect weight loss of mice infected with rodent malaria at all doses levels (p \> 0.05)) and no significant difference was observed between the experimental arm and the untreated groups ([Table 3](#T3){ref-type="table"}).

###### 

Effects of 70% methanol extracts of both plant materials on body weights of *P. berghei* infected mice in the antiplasmodial activity studies

  Body weight (gm)                                            
  ------------------ ------------ ------------- ------------- -------
  *E. kebericho*     1000         33.20±2.200   31.60 ±1.60   0.001
                     500          31.20±0.97    28.40±1.50    0.009
                     250          31.20±2.50    28.60±2.70    0.007
  *Z. officinale*    1000         32.20±0.970   26.50±1.17    0.00
                     500          30.00±1.00    26.00±0.81    0.00
                     250          27.40±2.31    24.60±2.23    0.002
  25 mg/kg CQ        24.40±1.88   24.40±1.88    22.80±1.65    0.016
  Negative control   26.60±4.00   26.60±4.00    31.0±3.51     0.054

**Key:** Values are significant at 95% CI and p-value \<0.05: TWN80=Tween 80, n=5

Assessment of the mean survival times of mice in all test groups was compared to the negative control groups ([Table 4](#T4){ref-type="table"}). It was also observed that mice treated with all doses of extracts lived longer than the negative control in a dose dependent manner. The study showed that 70% methanol crude extracts were able to protect reduction in PCV in a dose depended manner when compared to the control groups ([Table 5](#T5){ref-type="table"}).

###### 

The effects of 70 % methanol rhizome extracts of *E. kebericho* Mesfin and *Z. officinale Roscoe* on PCV of *P. berghei* infected treated mice

  Extract doses      PCV (%) on day 4   
  ------------------ ------------------ -------------
  1000mg/kg          45.96±1.08         33.46±1.08
  500mg/kg           39.70±0.44         20.04±0.32
  250mg/kg           33.00±0.81         22.10±1.18
  25 mg/kg CQ        49.62± 0.34        49.62± 0.34
  Negative control   20.98±0.70         20.98±0.70

Discussion
==========

Using plants as traditional remedies started from the antiquity to the present day for every day health care needs of human being including malaria ([@R36]). Accordingly, about 90% of Ethiopians, and 80% of the world population rely primarily on plant products for their healthcare for more than a century ([@R10]). Societies always believe that plant product is safe, non-toxic or have negligible health hazards. Accordingly, *E. Kebericho* Mesfin and *Z. officinale* Roscoe are among traditionally used medicinal plants against wide ranges of diseases including malaria in Ethiopia ([@R37]). *P. berghei* causes acute malaria in rodents and sensitive to CQ and non-infectious to human. It is is widely used elsewhere in the world for *in vivo* evaluation of antimalarial agents. The oral acute toxicity evaluation of .n*E. Kebericho* Mesfin was conducted prior to antiplasmodial studies to rule out the LD50. Hence, the current finding showed that 70% methanolic rhizome extract of the plant was non-toxic at 5 g/ kg of body weight in all study parameters.

The antiplasmodial activities of both plant materials in a four day suppressive test showed remarkable chemo - suppression of 49.53 ± 1.90% and 32.83 ± 1.03 respectively .The finding further reflected that the corresponding longer mean survival times compared to all other doses and the negative controls in a dose dependent manner. This suggests that 1000 mg/kg of an extract of *E. Kebericho* Mesfin might be the desirable therapeutic dose in the experimental animals. Increasing the dose of *Z. officinale* Roscoe beyond 1000 mg/kg body weight could result in best chemo - suppressive effect than the currently explained findings.

The antiplasmodial activities of these plants suggest that inhibitory effects on parasite replication. These could be due to the presence of active compounds in the test extracts ([@R38]--[@R40]) that are evenly distributed among plant species of the family. Studies elsewhere revealed that high degree of parasitemia suppression might be explained by mechanisms of biomarker actions having an indirect effect on the immune system or by other pathways that are not yet fully understood ([@R41]) in mice.

Previously isolated chemical compounds from Echinops species include alkaloids, saponins, phytosterols, polyphenols, carotenoids, Sesquiterpenes (alcohols/ lactones), lignans, acetylenic & thiophene compounds and essential oil. Specially, *Sesquiterpenes* was claimed to be antimalarial agents ([@R42]) which strongly supports the current finding. In vitro studies from the family Asteraceae like *Dicoma tomentosa* ([@R43]), *Microglossa pyrifolia* ([@R44]), *Oncosiphon piluliferum, Artemisia gorgonum Webb, Anthemis auriculata Boiss* (45) reported to show antiplasmodial activities against *P. falciparum*. Thus, this evidence coupled with the traditional claims suggested the antiplasmodial biomarkers are evenly distributed among the species of the same family. The antiplasmodial effect of *Z. officinale Roscoe* is also in support with previous in vitro studies such as *Aframomum zambesiacum K. Schum* and *Kaempferia marginata Carey* reported to have antiplasmodial activities from the family Zingiberaceae (45).

The current findings are strongly supported by two evidences. First, the traditional claims of both plants as antimalarial remedies. Secondly, the presence of *Sesquiterpenes* as an antiplasmodial agent in the crude extract of *E. kebericho* Mesfin and *in viro* studies of both plant species of the same families.

In conclusion, at the maximum experimental dose level of 5g/kg, *E. Kebericho* Mesfin showed no acute toxicity; and therefore, the LD50 of the plant was found to be beyond the concentration we used. The 70% methanolic extracts of both plants showed a dose dependent suppression of parasitemia. Hence, this study indicated that both plants have promising antiplasmodial activities against *P. berghei* whichsupports their traditional uses. Finally, the authors recommend that further in vitro studies on *P. falciparum* should be conducted to validate the antiplasmodial activities of both plants for routine health care use.
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